19 June 2002
Human Cytomegalovirus Infection and Abortion: an Immunohistochemical Study
Liliana Cruz Spano, Fausto Edmundo Lima Pereira, Nádia Gomes da Silva Basso, Paulo Roberto Mercon-de-VargasMed Sci Monit 2002; 8(6): BR230-235 :: ID: 420792
Abstract
BACKGROUND: Cytomegalovirus (HCMV) has been described in abortion tissues,but seldom associated with inclusion bodies. However, the possible pathogenic role of this virus in abortionis under discussion. We attempted to verify the relationship between HCMV antigens in tissues from firsttrimester abortions presenting with inflammatory lesions.MATERIAL/METHODS: Sixteen cases of first trimesterabortions with inflammatory lesions were selected from 340 cases studied at the Pathology Unit of theUniversity Hospital in Vit ria, Esp rito Santo State, Brazil. Paraffin-embedded sections were subjectedto indirect immunofluorescence (IFI) and immunoperoxidase (PAP), using monoclonal antibodies directedagainst immediate early (IEA) and late antigens (LA) of HCMV.RESULTS: Twelve out of sixteen cases (75%)presented at least one HCMV antigen. Eight cases presented both antigens, three cases only the IEA andone case only the LA. These antigens were present in decidual cells, in stromal cells of chorionic villiand in trophoblastic cells.CONCLUSIONS: The results showed high frequency of HCMV antigens in tissuesfrom first trimester abortion. This frequency, higher than that previously reported, was probably dueto the fact that necro-inflammatory lesions were always present in selected cases. The presence of LAin trophoblastic cells is evidence for cell permissiveness to viral replication in vivo. The resultsshowing high presence of HCMV antigens in tissues from abortion with inflammatory lesions suggest a possiblerelationship of HCMV infection with inflammation and pregnancy loss.
Keywords: Abortion, Spontaneous, Antibodies, Monoclonal, Antigens, Viral, Fluorescent Antibody Technique, Indirect, Pregnancy, Pregnancy Trimester, First
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952